Department of Medicine
-
October 7, 2021
Study finds genetic testing useful for young AFib patients
Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed. -
October 7, 2021
Lindenfeld honored by Heart Failure Society of America
Vanderbilt's JoAnn Lindenfeld, MD, has received the Pioneer Award from the Heart Failure Society of America (HFSA) for being an innovator and pioneer in the field of heart failure. -
September 30, 2021
Policy formalizes role and use of medical chaperones during patient encounters
Vanderbilt University Medical Center is implementing a new policy which standardizes and expands the role of a medical chaperone, an individual who serves as a witness for both a patient and their clinician during a sensitive medical examination or procedure. -
September 30, 2021
Study shows how a protein coding gene confers breast cancer susceptibility during DNA transcription
Vanderbilt-Ingram Cancer Center research is providing new insights into how genetic variants convey breast cancer susceptibility by altering the transcription factor proteins that convert DNA strands into RNA. -
September 23, 2021
Stevenson receives HFSA Lifetime Achievement Award
Vanderbilt's Lynne Warner Stevenson, MD, has received the Lifetime Achievement Award from the Heart Failure Society of America. -
September 23, 2021
Eng named co-chair of NCI clinical trials steering committee
Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee. -
September 21, 2021
The role of polarity in early cancer
Mutations in the protein epiregulin, an EGF receptor ligand, affect larger epithelial cell reorganization and may contribute to early cancer development, Vanderbilt researchers discovered.